• Login as Editor
    View Item 
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Adenovirus immunoregulatory proteins and control of NF-kappaB

    Thumbnail
    Date
    2001
    Author
    Ye, Jianjiang
    Metadata
    Show full item record
    Abstract
    Adenovirus early region 3 (B) encodes a group of small proteins that regulate host immune responses during virus infection. These proteins are generally referred to by their molecular weight, such as 14.7K, 10.4K and 14.5K. The E3-14.7K protein is an inhibitor of tumor necrosis factor (TNF) alpha-induced cell death. FIP3, isolated as a 14.7K-interacting protein, is an essential component of the multimeric IkappaBalpha kinase (IKK) complex and has been shown to interact with various components (RIP, NIK, IKKbeta) of the NFkappaB activation pathway. FIP3 has also been isolated by other groups and has been given different names, such as IKKgamma and NEMO. FIP3 has been shown to repress basal and TNFalpha-induced NFkappaB activity as well as to induce cell-death when overexpressed. In the current study, we generated a series of deletion mutants and mapped the domains of FIP3 which are responsible for its various functions. Our results suggested that FIP3 might serve as a scaffold protein to organize the various components of the IKK complex. We also found that the carboxyl-terminal half of FIP3 blocked TNFalpha-induced IkappaBalpha phosphorylation and degradation, and in addition we demonstrated that FIP3 inhibited the p65 transactivation activity, suggesting that FIP3 may use multiple strategies to inhibit NFkappaB. We also showed that overexpression of IKKbeta inhibited p65 transactivation activity, suggesting that this feature might be part of a general feedback control mechanism to fine tune NFkappaB activity after stimulation.;E3-10.4K and E3-14.5K proteins act as a complex to inhibit TNFalpha-induced cytolysis. They also cause FAS r&barbelow;eceptor i&barbelow;nternalization and d&barbelow;egradation and thus were renamed as RIDalpha and RIDbeta respectively. TNFalpha treatment also leads to the activation of an NFkappaB stimulation pathway. The activation of NFkappaB is generally regarded as protective against apoptosis since it upregulates the expression of a group of cellular proteins that inhibit cell-death. In our studies we found that RIDalpha/beta complex upregulated NFkappaB activity. This complex did not induce IkappaBalpha phosphorylation and degradation, or NFkappaB nuclear translocation. We found that RIDalpha/beta complex acted synergistically with overexpressed p65 to activate an NFkappaB reporter. Additionally we demonstrated that RIDalpha/beta complex moderately upregulated p65 transactivation activity. Our studies suggested that adenovirus E3-RIDalpha/beta might inhibit or attenuate cell-death by targeting the NFkappaB pathway.
    Permanent Link(s)
    https://yulib002.mc.yu.edu/login?url=http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:3003398
    https://hdl.handle.net/20.500.12202/514
    Collections
    • Albert Einstein College of Medicine: Doctoral Dissertations [1674]

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University
     

     

    Browse

    AllCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login as Editor

    Statistics

    View Usage Statistics

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University